Theravance Respiratory Company, LLC (Tables)

12 Months Ended

Dec. 31, 2020

Theravance Respiratory Company, LLC

Summary financial information

(In thousands)	2020		2019		2018
Current assets	$	63,027	$	36,737
Non-current assets		16,959		—
Current liabilities		508		3,069
Royalty revenue for the year ended		73,089		42,790	$	13,379
Revenue from collaborative arrangements for the year ended		10,000		—		—
Income from continuing operations and net income for the year ended	$	81,662	$	39,653	$	13,261